Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
Clinical trial NCT04551131 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04551131
- Sponsor
- St. Jude Children's Research Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-13
- Primary completion
- 2025-11-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.